Author: Luis Soler Rivera
New Heart Failure Treatment in View
A recent study of heart failure patients at UVA Health revealed that colchicine, a common gout medication, significantly improved survival rates.
After Several Failed Spine Surgeries, This Expert Team Finally Brought Relief
Five spine surgeries left this patient in constant pain. Here's how UVA Health surgeons used innovative techniques to finally deliver relief.
Growth Modulation in Pediatric Scoliosis at UVA Health: Expanding the Scope of Care
See the impact we're making by participating in a study for ApiFix, a ratcheting, nonfusion device for growth modulation in pediatric scoliosis.
The Benefits of Big Data in a Global Study of Huntington’s Disease
UVA Health neurologists are helping to improve the understanding and clinical care of Huntington's disease by contributing to a global observational study.
Can We Prevent Neuron Death? Getting to the Root of Alzheimer’s Disease
Research into neuron death in Alzheimer's disease at UVA Health has laid the groundwork for clinical studies aimed at improving patient prognosis.
How Hand Surgeons Help After Spinal Cord Injury
A UVA Health surgeon implores PMR physicians to refer any patient with a T1 or higher cervical spinal cord injury to a hand surgeon for evaluation. Find out why.
Foot & Ankle Innovations That Began on the Playing Field
UVA Health orthopedic experts developed new techniques to treat high ankle sprain, Achilles tendon rupture, and Lisfranc injury — and then applied these approaches to all patients.
UVA Health Researcher Brings Clarity to Status Epilepticus Interventions
UVA Health research sheds light on the best second-line treatment for status epilepticus, a neurological emergency that can cause brain damage or even death.
UVA Health Genetic Research Lays Groundwork for Future Stroke Care
An international UVA Health research partnership with the ISGC has uncovered previously unknown genetic mechanisms related to stroke risk. These studies underline UVA Health's commitment to prevent stroke and improve treatment.
UVA Health Uncovers Genetic Components of Type 1 Diabetes That Could Lead to New Screening Guidelines
Over the past 2 decades, a UVA researcher has found new sites in the genome related to type 1 diabetes that could revolutionize screening and therapy.